This FTSE 250 stock looks fully valued for now. Here’s where I’ve put my ISA cash instead

Another good set of numbers from this FTSE 250 (INDEXFTSE: MCX) stock, but this Fool thinks there’s another quality stock available at a far better price.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Back in January, I came to the conclusion that IRN BRU producer AG Barr (LSE: BAG) was probably a better buy than tonic water specialist (and market darling) Fevertree, thanks mostly to the latter’s lofty valuation. 

This isn’t to say, however, that there aren’t better opportunities for making money elsewhere in the market.

Before giving an example, let’s look through today’s solid (if not astounding) full-year numbers from the Barr business. 

Resilient but pricey

Revenue rose 5.6% to £279m over the 52 weeks to 26 January with the company reporting a “significant increase in volume share” in the UK market. Pre-tax profit before exceptional items rose 2.5% to £45.2m and net cash grew 45% — higher than expected — to £21.8m.

Commenting on today’s results, CEO Roger White said its strategy and execution were “fit for purpose and resilient,” even if uncertainty abounds in the UK economy. He went on to say that the robustness of the company’s markets gives it “continued opportunities to grow.”

With 99% of its soft drinks portfolio now exempt, it would also appear clear that the introduction of the sugar drinks industry levy (otherwise known as the ‘sugar tax’) is unlikely to have a significant impact on the mid-cap’s ability to continue growing revenue and profits. 

Despite all this and AG Barr’s well-earned status as a quality stock, I can’t necessarily see many investors jumping to own based on the current valuation.

A price-to-earnings (P/E) ratio of 23 for the next year is above its five-year average of just under 20 and it’s hard to see why the shares might fizz much higher in the near term.

Income investors are unlikely to be interested either. Today’s final dividend of 12.74p per share gives a total payout of 16.64p per share for the year. That may be 7% more than last year, but it still only gives a trailing yield of 2.2%. 

As mentioned, I think there’s another company that could offer far better returns to investors.

Going cheap

CFD and spread-betting provider IG Group (LSE: IGG) had a shocker last week, falling 10% in value in just a couple of days. That came after revealing a 12% reduction in net trading revenue in Q3 compared to Q2 as a result of increased industry regulation.  

Personally, I see this as a great opportunity to acquire a slice of a company that’s a global leader in what it does. 

On a P/E of just 11 for the year, IG looks cheap considering its history of generating exceptional returns on the money it invests. There’s a truckload of cash on the balance sheet and the firm has also committed to returning 43.2p per share in the current financial year, which translates to a mouth-watering 8.5% at the time of writing.

Even if cash payouts were to be slightly reduced as a precautionary measure in the future, I’m confident the income on offer will still be worth grabbing while IG continues to adapt to the new trading environment. The fact that it still doesn’t attract anywhere near the same interest from short sellers as rival Plus 500 is telling too.  

Is IG in a tricky spot? Yes. Could it get worse? Possibly. Do I expect it recover in time? Absolutely. And that’s why it’s now earned a place in my ISA portfolio.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Paul Summers owns shares in IG Group. The Motley Fool UK has recommended AG Barr. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »